Neuroscience
From the website of The Washington Post:
FDA OKs First Attention Deficit Patch
By ANDREW BRIDGES
The Associated Press
Thursday, April 6, 2006; 8:06 PM
WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity disorder in children.
The patch called Daytrana, designed to be worn for 9 hours, contains methylphenidate, which has been shown to help children with ADHD. It is the same stimulant that is in Ritalin. The patch is made by Noven Pharmaceuticals Inc. of Miami.
[ ... Read the full report ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Prescribed Stimulant Use For Adhd Continues To Rise Steadily
A press release from the NIH: Prescribed stimulant use for ADHD continues to rise steadily NIH and AHRQ study finds pace of the rise has slowed in recent years "The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder...
- Modafinil, Adhd, And The Fda
From The Washington Post: Use of Drug to Treat ADHD in Children Opposed Associated Press Friday, March 24, 2006; Page A11 The narcolepsy drug modafinil should not be approved as a treatment for attention-deficit hyperactivity disorder in children until...
- Methylphenidate
From The New York Times:Panel Recommends Warnings for Ritalin and Other Stimulants By THE ASSOCIATED PRESS Published: February 9, 2006 Filed at 4:13 p.m. ET WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious...
- In The Weeklies: Attention Deficit Hyperactivity Disorder (adhd)
This week's Morbidity and Mortaility Weekly Report (MMWR) includes an article about the prevelance and treatment of ADHD: Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder...
- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...
Neuroscience
Daytrana (Methylphenidate Patch) & ADHD
From the website of The Washington Post:
FDA OKs First Attention Deficit Patch
By ANDREW BRIDGES
The Associated Press
Thursday, April 6, 2006; 8:06 PM
WASHINGTON -- The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity disorder in children.
The patch called Daytrana, designed to be worn for 9 hours, contains methylphenidate, which has been shown to help children with ADHD. It is the same stimulant that is in Ritalin. The patch is made by Noven Pharmaceuticals Inc. of Miami.
[ ... Read the full report ... ]
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Prescribed Stimulant Use For Adhd Continues To Rise Steadily
A press release from the NIH: Prescribed stimulant use for ADHD continues to rise steadily NIH and AHRQ study finds pace of the rise has slowed in recent years "The prescribed use of stimulant medications to treat attention deficit hyperactivity disorder...
- Modafinil, Adhd, And The Fda
From The Washington Post: Use of Drug to Treat ADHD in Children Opposed Associated Press Friday, March 24, 2006; Page A11 The narcolepsy drug modafinil should not be approved as a treatment for attention-deficit hyperactivity disorder in children until...
- Methylphenidate
From The New York Times:Panel Recommends Warnings for Ritalin and Other Stimulants By THE ASSOCIATED PRESS Published: February 9, 2006 Filed at 4:13 p.m. ET WASHINGTON (AP) -- Federal science advisers voted narrowly Thursday to recommend the most serious...
- In The Weeklies: Attention Deficit Hyperactivity Disorder (adhd)
This week's Morbidity and Mortaility Weekly Report (MMWR) includes an article about the prevelance and treatment of ADHD: Mental Health in the United States: Prevalence of Diagnosis and Medication Treatment for Attention-Deficit/Hyperactivity Disorder...
- Adhd Treatment
The full-text contents of the following article is available on the Pediatrics website at this link [Click here]: Ronald T. Brown, Robert W. Amler, Wendy S. Freeman, James M. Perrin, Martin T. Stein, Heidi M. Feldman, Karen Pierce, Mark L. Wolraich and...